TrialHypertension (Dallas, Tex. : 1979)2026

Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

Bonnie Ky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.